Global Medical Morphine Market Growth 2026-2032
The global Medical Morphine market size is predicted to grow from US$ 4383 million in 2025 to US$ 5504 million in 2032; it is expected to grow at a CAGR of 3.3% from 2026 to 2032.
In 2025, global Medical Morphine output reached about 16 billion dosage units and global capacity of around 18 billion dosage units. The average price is about USD 0.28 per dosage unit, with gross margins near 45%. Medical Morphine is a pharmaceutical-grade opioid analgesic derived primarily from purified morphine extracted from opium poppy (Papaver somniferum) latex or, in limited cases, produced through semi-synthetic or biotechnological processes under strict regulatory control. It is widely used for the management of moderate to severe acute and chronic pain, postoperative pain, cancer pain, trauma, and palliative care, and is formulated into injectable solutions, oral tablets, capsules, oral liquids, sustained-release formulations, suppositories, and other dosage forms that comply with pharmacopeial standards. The Medical Morphine supply chain begins with the licensed cultivation of opium poppies and harvesting of opium or poppy straw, followed by alkaloid extraction, purification, and production of pharmaceutical-grade morphine active pharmaceutical ingredient (API). The API is then supplied to pharmaceutical manufacturers for formulation, sterile processing where required, filling, packaging, quality control testing, and regulatory release. Finished products are distributed through licensed pharmaceutical wholesalers, hospitals, clinics, retail pharmacies, and government-controlled healthcare systems, with comprehensive security, traceability, and compliance measures maintained throughout the entire supply chain due to the narcotic and controlled-substance status of morphine.
The Medical Morphine market is being driven by the growing global prevalence of cancer, an aging population, increasing numbers of surgical procedures, and the rising incidence of chronic pain, trauma, and palliative care cases that require effective opioid analgesia. Continued expansion of healthcare infrastructure in emerging economies, improved access to essential pain management medicines through government and international healthcare initiatives, and increasing availability of generic morphine products are supporting broader market adoption. Demand is also benefiting from the development of extended-release formulations, abuse-deterrent technologies, patient-controlled analgesia (PCA) systems, and preservative-free injectable products for specialized clinical applications. In addition, greater investment in hospital care, oncology treatment, hospice services, and home-based palliative care is increasing consumption of medical morphine. Although stricter opioid regulations and concerns over misuse have moderated growth in some developed markets, the essential role of morphine in severe pain management, its inclusion on many national essential medicines lists, and ongoing improvements in pharmaceutical manufacturing quality and supply chain reliability continue to support steady long-term market growth.
LP Information, Inc. (LPI) ' newest research report, the “Medical Morphine Industry Forecast” looks at past sales and reviews total world Medical Morphine sales in 2025, providing a comprehensive analysis by region and market sector of projected Medical Morphine sales for 2026 through 2032. With Medical Morphine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Medical Morphine industry.
This Insight Report provides a comprehensive analysis of the global Medical Morphine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Medical Morphine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Medical Morphine market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Medical Morphine and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Medical Morphine.
This report presents a comprehensive overview, market shares, and growth opportunities of Medical Morphine market by product type, application, key manufacturers and key regions and countries.
In 2025, global Medical Morphine output reached about 16 billion dosage units and global capacity of around 18 billion dosage units. The average price is about USD 0.28 per dosage unit, with gross margins near 45%. Medical Morphine is a pharmaceutical-grade opioid analgesic derived primarily from purified morphine extracted from opium poppy (Papaver somniferum) latex or, in limited cases, produced through semi-synthetic or biotechnological processes under strict regulatory control. It is widely used for the management of moderate to severe acute and chronic pain, postoperative pain, cancer pain, trauma, and palliative care, and is formulated into injectable solutions, oral tablets, capsules, oral liquids, sustained-release formulations, suppositories, and other dosage forms that comply with pharmacopeial standards. The Medical Morphine supply chain begins with the licensed cultivation of opium poppies and harvesting of opium or poppy straw, followed by alkaloid extraction, purification, and production of pharmaceutical-grade morphine active pharmaceutical ingredient (API). The API is then supplied to pharmaceutical manufacturers for formulation, sterile processing where required, filling, packaging, quality control testing, and regulatory release. Finished products are distributed through licensed pharmaceutical wholesalers, hospitals, clinics, retail pharmacies, and government-controlled healthcare systems, with comprehensive security, traceability, and compliance measures maintained throughout the entire supply chain due to the narcotic and controlled-substance status of morphine.
The Medical Morphine market is being driven by the growing global prevalence of cancer, an aging population, increasing numbers of surgical procedures, and the rising incidence of chronic pain, trauma, and palliative care cases that require effective opioid analgesia. Continued expansion of healthcare infrastructure in emerging economies, improved access to essential pain management medicines through government and international healthcare initiatives, and increasing availability of generic morphine products are supporting broader market adoption. Demand is also benefiting from the development of extended-release formulations, abuse-deterrent technologies, patient-controlled analgesia (PCA) systems, and preservative-free injectable products for specialized clinical applications. In addition, greater investment in hospital care, oncology treatment, hospice services, and home-based palliative care is increasing consumption of medical morphine. Although stricter opioid regulations and concerns over misuse have moderated growth in some developed markets, the essential role of morphine in severe pain management, its inclusion on many national essential medicines lists, and ongoing improvements in pharmaceutical manufacturing quality and supply chain reliability continue to support steady long-term market growth.
LP Information, Inc. (LPI) ' newest research report, the “Medical Morphine Industry Forecast” looks at past sales and reviews total world Medical Morphine sales in 2025, providing a comprehensive analysis by region and market sector of projected Medical Morphine sales for 2026 through 2032. With Medical Morphine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Medical Morphine industry.
This Insight Report provides a comprehensive analysis of the global Medical Morphine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Medical Morphine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Medical Morphine market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Medical Morphine and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Medical Morphine.
This report presents a comprehensive overview, market shares, and growth opportunities of Medical Morphine market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Immediate-Release (IR)
- Controlled-Release (CR)
- Sustained-Release (SR)
Segmentation by Strength:
- <15 mg
- 15–30 mg
- 30–60 mg
- 60–100 mg
- >100 mg
Segmentation by Sterility:
- Sterile Injectable Grade
- Non-Sterile Oral Grade
Segmentation by Application:
- Acute Pain Management
- Chronic Pain Management
This report also splits the market by region:
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Jiangsu Nhwa Pharmaceutical
- Humanwell Healthcare Group
- Mallinckrodt Pharmaceuticals
- Hikma Pharmaceuticals
- Viatris
- Pfizer
- Fresenius Kabi
- Hameln Pharma
- Teva Pharmaceutical
- Sun Pharmaceutical
- Amneal Pharmaceuticals
- Rhodes Pharmaceuticals
- Purdue Pharma
- Sandoz
- Alcaliber
- Tasmanian Alkaloids
- G.L. Pharma
- Martindale Pharma
Key Questions Addressed in this Report
- What is the 10-year outlook for the global Medical Morphine market?
- What factors are driving Medical Morphine market growth, globally and by region?
- Which technologies are poised for the fastest growth by market and region?
- How do Medical Morphine market opportunities vary by end market size?
- How does Medical Morphine break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Medical Morphine Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Medical Morphine by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Medical Morphine by Country/Region, 2021, 2025 & 2032
2.2 Medical Morphine Segment by Type
2.2.1 Immediate-Release (IR)
2.2.2 Controlled-Release (CR)
2.2.3 Sustained-Release (SR)
2.2.4 Medical Morphine Sales by Type
2.2.4.1 Global Medical Morphine Sales Market Share by Type (2021-2026)
2.2.4.2 Global Medical Morphine Revenue and Market Share by Type (2021-2026)
2.2.4.3 Global Medical Morphine Sale Price by Type (2021-2026)
2.3 Medical Morphine Segment by Strength
2.3.1 <15 mg
2.3.2 15–30 mg
2.3.3 30–60 mg
2.3.4 60–100 mg
2.3.5 >100 mg
2.3.6 Medical Morphine Sales by Strength
2.3.6.1 Global Medical Morphine Sales Market Share by Strength (2021-2026)
2.3.6.2 Global Medical Morphine Revenue and Market Share by Strength (2021-2026)
2.3.6.3 Global Medical Morphine Sale Price by Strength (2021-2026)
2.4 Medical Morphine Segment by Sterility
2.4.1 Sterile Injectable Grade
2.4.2 Non-Sterile Oral Grade
2.4.3 Medical Morphine Sales by Sterility
2.4.3.1 Global Medical Morphine Sales Market Share by Sterility (2021-2026)
2.4.3.2 Global Medical Morphine Revenue and Market Share by Sterility (2021-2026)
2.4.3.3 Global Medical Morphine Sale Price by Sterility (2021-2026)
2.5 Medical Morphine Segment by Application
2.5.1 Acute Pain Management
2.5.2 Chronic Pain Management
2.5.3 Medical Morphine Sales by Application
2.5.3.1 Global Medical Morphine Sale Market Share by Application (2021-2026)
2.5.3.2 Global Medical Morphine Revenue and Market Share by Application (2021-2026)
2.5.3.3 Global Medical Morphine Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Medical Morphine Breakdown Data by Company
3.1.1 Global Medical Morphine Annual Sales by Company (2021-2026)
3.1.2 Global Medical Morphine Sales Market Share by Company (2021-2026)
3.2 Global Medical Morphine Annual Revenue by Company (2021-2026)
3.2.1 Global Medical Morphine Revenue by Company (2021-2026)
3.2.2 Global Medical Morphine Revenue Market Share by Company (2021-2026)
3.3 Global Medical Morphine Sale Price by Company
3.4 Key Manufacturers Medical Morphine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Medical Morphine Product Location Distribution
3.4.2 Players Medical Morphine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR MEDICAL MORPHINE BY GEOGRAPHIC REGION
4.1 World Historic Medical Morphine Market Size by Geographic Region (2021-2026)
4.1.1 Global Medical Morphine Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Medical Morphine Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Medical Morphine Market Size by Country/Region (2021-2026)
4.2.1 Global Medical Morphine Annual Sales by Country/Region (2021-2026)
4.2.2 Global Medical Morphine Annual Revenue by Country/Region (2021-2026)
4.3 Americas Medical Morphine Sales Growth
4.4 APAC Medical Morphine Sales Growth
4.5 Europe Medical Morphine Sales Growth
4.6 Middle East & Africa Medical Morphine Sales Growth
5 AMERICAS
5.1 Americas Medical Morphine Sales by Country
5.1.1 Americas Medical Morphine Sales by Country (2021-2026)
5.1.2 Americas Medical Morphine Revenue by Country (2021-2026)
5.2 Americas Medical Morphine Sales by Type (2021-2026)
5.3 Americas Medical Morphine Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Medical Morphine Sales by Region
6.1.1 APAC Medical Morphine Sales by Region (2021-2026)
6.1.2 APAC Medical Morphine Revenue by Region (2021-2026)
6.2 APAC Medical Morphine Sales by Type (2021-2026)
6.3 APAC Medical Morphine Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Medical Morphine by Country
7.1.1 Europe Medical Morphine Sales by Country (2021-2026)
7.1.2 Europe Medical Morphine Revenue by Country (2021-2026)
7.2 Europe Medical Morphine Sales by Type (2021-2026)
7.3 Europe Medical Morphine Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Medical Morphine by Country
8.1.1 Middle East & Africa Medical Morphine Sales by Country (2021-2026)
8.1.2 Middle East & Africa Medical Morphine Revenue by Country (2021-2026)
8.2 Middle East & Africa Medical Morphine Sales by Type (2021-2026)
8.3 Middle East & Africa Medical Morphine Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Medical Morphine
10.3 Manufacturing Process Analysis of Medical Morphine
10.4 Industry Chain Structure of Medical Morphine
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Medical Morphine Distributors
11.3 Medical Morphine Customer
12 WORLD FORECAST REVIEW FOR MEDICAL MORPHINE BY GEOGRAPHIC REGION
12.1 Global Medical Morphine Market Size Forecast by Region
12.1.1 Global Medical Morphine Forecast by Region (2027-2032)
12.1.2 Global Medical Morphine Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Medical Morphine Forecast by Type (2027-2032)
12.7 Global Medical Morphine Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Jiangsu Nhwa Pharmaceutical
13.1.1 Jiangsu Nhwa Pharmaceutical Company Information
13.1.2 Jiangsu Nhwa Pharmaceutical Medical Morphine Product Portfolios and Specifications
13.1.3 Jiangsu Nhwa Pharmaceutical Medical Morphine Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Jiangsu Nhwa Pharmaceutical Main Business Overview
13.1.5 Jiangsu Nhwa Pharmaceutical Latest Developments
13.2 Humanwell Healthcare Group
13.2.1 Humanwell Healthcare Group Company Information
13.2.2 Humanwell Healthcare Group Medical Morphine Product Portfolios and Specifications
13.2.3 Humanwell Healthcare Group Medical Morphine Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Humanwell Healthcare Group Main Business Overview
13.2.5 Humanwell Healthcare Group Latest Developments
13.3 Mallinckrodt Pharmaceuticals
13.3.1 Mallinckrodt Pharmaceuticals Company Information
13.3.2 Mallinckrodt Pharmaceuticals Medical Morphine Product Portfolios and Specifications
13.3.3 Mallinckrodt Pharmaceuticals Medical Morphine Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Mallinckrodt Pharmaceuticals Main Business Overview
13.3.5 Mallinckrodt Pharmaceuticals Latest Developments
13.4 Hikma Pharmaceuticals
13.4.1 Hikma Pharmaceuticals Company Information
13.4.2 Hikma Pharmaceuticals Medical Morphine Product Portfolios and Specifications
13.4.3 Hikma Pharmaceuticals Medical Morphine Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Hikma Pharmaceuticals Main Business Overview
13.4.5 Hikma Pharmaceuticals Latest Developments
13.5 Viatris
13.5.1 Viatris Company Information
13.5.2 Viatris Medical Morphine Product Portfolios and Specifications
13.5.3 Viatris Medical Morphine Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Viatris Main Business Overview
13.5.5 Viatris Latest Developments
13.6 Pfizer
13.6.1 Pfizer Company Information
13.6.2 Pfizer Medical Morphine Product Portfolios and Specifications
13.6.3 Pfizer Medical Morphine Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Pfizer Main Business Overview
13.6.5 Pfizer Latest Developments
13.7 Fresenius Kabi
13.7.1 Fresenius Kabi Company Information
13.7.2 Fresenius Kabi Medical Morphine Product Portfolios and Specifications
13.7.3 Fresenius Kabi Medical Morphine Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Fresenius Kabi Main Business Overview
13.7.5 Fresenius Kabi Latest Developments
13.8 Hameln Pharma
13.8.1 Hameln Pharma Company Information
13.8.2 Hameln Pharma Medical Morphine Product Portfolios and Specifications
13.8.3 Hameln Pharma Medical Morphine Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Hameln Pharma Main Business Overview
13.8.5 Hameln Pharma Latest Developments
13.9 Teva Pharmaceutical
13.9.1 Teva Pharmaceutical Company Information
13.9.2 Teva Pharmaceutical Medical Morphine Product Portfolios and Specifications
13.9.3 Teva Pharmaceutical Medical Morphine Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Teva Pharmaceutical Main Business Overview
13.9.5 Teva Pharmaceutical Latest Developments
13.10 Sun Pharmaceutical
13.10.1 Sun Pharmaceutical Company Information
13.10.2 Sun Pharmaceutical Medical Morphine Product Portfolios and Specifications
13.10.3 Sun Pharmaceutical Medical Morphine Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Sun Pharmaceutical Main Business Overview
13.10.5 Sun Pharmaceutical Latest Developments
13.11 Amneal Pharmaceuticals
13.11.1 Amneal Pharmaceuticals Company Information
13.11.2 Amneal Pharmaceuticals Medical Morphine Product Portfolios and Specifications
13.11.3 Amneal Pharmaceuticals Medical Morphine Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 Amneal Pharmaceuticals Main Business Overview
13.11.5 Amneal Pharmaceuticals Latest Developments
13.12 Rhodes Pharmaceuticals
13.12.1 Rhodes Pharmaceuticals Company Information
13.12.2 Rhodes Pharmaceuticals Medical Morphine Product Portfolios and Specifications
13.12.3 Rhodes Pharmaceuticals Medical Morphine Sales, Revenue, Price and Gross Margin (2021-2026)
13.12.4 Rhodes Pharmaceuticals Main Business Overview
13.12.5 Rhodes Pharmaceuticals Latest Developments
13.13 Purdue Pharma
13.13.1 Purdue Pharma Company Information
13.13.2 Purdue Pharma Medical Morphine Product Portfolios and Specifications
13.13.3 Purdue Pharma Medical Morphine Sales, Revenue, Price and Gross Margin (2021-2026)
13.13.4 Purdue Pharma Main Business Overview
13.13.5 Purdue Pharma Latest Developments
13.14 Sandoz
13.14.1 Sandoz Company Information
13.14.2 Sandoz Medical Morphine Product Portfolios and Specifications
13.14.3 Sandoz Medical Morphine Sales, Revenue, Price and Gross Margin (2021-2026)
13.14.4 Sandoz Main Business Overview
13.14.5 Sandoz Latest Developments
13.15 Alcaliber
13.15.1 Alcaliber Company Information
13.15.2 Alcaliber Medical Morphine Product Portfolios and Specifications
13.15.3 Alcaliber Medical Morphine Sales, Revenue, Price and Gross Margin (2021-2026)
13.15.4 Alcaliber Main Business Overview
13.15.5 Alcaliber Latest Developments
13.16 Tasmanian Alkaloids
13.16.1 Tasmanian Alkaloids Company Information
13.16.2 Tasmanian Alkaloids Medical Morphine Product Portfolios and Specifications
13.16.3 Tasmanian Alkaloids Medical Morphine Sales, Revenue, Price and Gross Margin (2021-2026)
13.16.4 Tasmanian Alkaloids Main Business Overview
13.16.5 Tasmanian Alkaloids Latest Developments
13.17 G.L. Pharma
13.17.1 G.L. Pharma Company Information
13.17.2 G.L. Pharma Medical Morphine Product Portfolios and Specifications
13.17.3 G.L. Pharma Medical Morphine Sales, Revenue, Price and Gross Margin (2021-2026)
13.17.4 G.L. Pharma Main Business Overview
13.17.5 G.L. Pharma Latest Developments
13.18 Martindale Pharma
13.18.1 Martindale Pharma Company Information
13.18.2 Martindale Pharma Medical Morphine Product Portfolios and Specifications
13.18.3 Martindale Pharma Medical Morphine Sales, Revenue, Price and Gross Margin (2021-2026)
13.18.4 Martindale Pharma Main Business Overview
13.18.5 Martindale Pharma Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Medical Morphine Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Medical Morphine by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Medical Morphine by Country/Region, 2021, 2025 & 2032
2.2 Medical Morphine Segment by Type
2.2.1 Immediate-Release (IR)
2.2.2 Controlled-Release (CR)
2.2.3 Sustained-Release (SR)
2.2.4 Medical Morphine Sales by Type
2.2.4.1 Global Medical Morphine Sales Market Share by Type (2021-2026)
2.2.4.2 Global Medical Morphine Revenue and Market Share by Type (2021-2026)
2.2.4.3 Global Medical Morphine Sale Price by Type (2021-2026)
2.3 Medical Morphine Segment by Strength
2.3.1 <15 mg
2.3.2 15–30 mg
2.3.3 30–60 mg
2.3.4 60–100 mg
2.3.5 >100 mg
2.3.6 Medical Morphine Sales by Strength
2.3.6.1 Global Medical Morphine Sales Market Share by Strength (2021-2026)
2.3.6.2 Global Medical Morphine Revenue and Market Share by Strength (2021-2026)
2.3.6.3 Global Medical Morphine Sale Price by Strength (2021-2026)
2.4 Medical Morphine Segment by Sterility
2.4.1 Sterile Injectable Grade
2.4.2 Non-Sterile Oral Grade
2.4.3 Medical Morphine Sales by Sterility
2.4.3.1 Global Medical Morphine Sales Market Share by Sterility (2021-2026)
2.4.3.2 Global Medical Morphine Revenue and Market Share by Sterility (2021-2026)
2.4.3.3 Global Medical Morphine Sale Price by Sterility (2021-2026)
2.5 Medical Morphine Segment by Application
2.5.1 Acute Pain Management
2.5.2 Chronic Pain Management
2.5.3 Medical Morphine Sales by Application
2.5.3.1 Global Medical Morphine Sale Market Share by Application (2021-2026)
2.5.3.2 Global Medical Morphine Revenue and Market Share by Application (2021-2026)
2.5.3.3 Global Medical Morphine Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Medical Morphine Breakdown Data by Company
3.1.1 Global Medical Morphine Annual Sales by Company (2021-2026)
3.1.2 Global Medical Morphine Sales Market Share by Company (2021-2026)
3.2 Global Medical Morphine Annual Revenue by Company (2021-2026)
3.2.1 Global Medical Morphine Revenue by Company (2021-2026)
3.2.2 Global Medical Morphine Revenue Market Share by Company (2021-2026)
3.3 Global Medical Morphine Sale Price by Company
3.4 Key Manufacturers Medical Morphine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Medical Morphine Product Location Distribution
3.4.2 Players Medical Morphine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR MEDICAL MORPHINE BY GEOGRAPHIC REGION
4.1 World Historic Medical Morphine Market Size by Geographic Region (2021-2026)
4.1.1 Global Medical Morphine Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Medical Morphine Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Medical Morphine Market Size by Country/Region (2021-2026)
4.2.1 Global Medical Morphine Annual Sales by Country/Region (2021-2026)
4.2.2 Global Medical Morphine Annual Revenue by Country/Region (2021-2026)
4.3 Americas Medical Morphine Sales Growth
4.4 APAC Medical Morphine Sales Growth
4.5 Europe Medical Morphine Sales Growth
4.6 Middle East & Africa Medical Morphine Sales Growth
5 AMERICAS
5.1 Americas Medical Morphine Sales by Country
5.1.1 Americas Medical Morphine Sales by Country (2021-2026)
5.1.2 Americas Medical Morphine Revenue by Country (2021-2026)
5.2 Americas Medical Morphine Sales by Type (2021-2026)
5.3 Americas Medical Morphine Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Medical Morphine Sales by Region
6.1.1 APAC Medical Morphine Sales by Region (2021-2026)
6.1.2 APAC Medical Morphine Revenue by Region (2021-2026)
6.2 APAC Medical Morphine Sales by Type (2021-2026)
6.3 APAC Medical Morphine Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Medical Morphine by Country
7.1.1 Europe Medical Morphine Sales by Country (2021-2026)
7.1.2 Europe Medical Morphine Revenue by Country (2021-2026)
7.2 Europe Medical Morphine Sales by Type (2021-2026)
7.3 Europe Medical Morphine Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Medical Morphine by Country
8.1.1 Middle East & Africa Medical Morphine Sales by Country (2021-2026)
8.1.2 Middle East & Africa Medical Morphine Revenue by Country (2021-2026)
8.2 Middle East & Africa Medical Morphine Sales by Type (2021-2026)
8.3 Middle East & Africa Medical Morphine Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Medical Morphine
10.3 Manufacturing Process Analysis of Medical Morphine
10.4 Industry Chain Structure of Medical Morphine
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Medical Morphine Distributors
11.3 Medical Morphine Customer
12 WORLD FORECAST REVIEW FOR MEDICAL MORPHINE BY GEOGRAPHIC REGION
12.1 Global Medical Morphine Market Size Forecast by Region
12.1.1 Global Medical Morphine Forecast by Region (2027-2032)
12.1.2 Global Medical Morphine Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Medical Morphine Forecast by Type (2027-2032)
12.7 Global Medical Morphine Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Jiangsu Nhwa Pharmaceutical
13.1.1 Jiangsu Nhwa Pharmaceutical Company Information
13.1.2 Jiangsu Nhwa Pharmaceutical Medical Morphine Product Portfolios and Specifications
13.1.3 Jiangsu Nhwa Pharmaceutical Medical Morphine Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Jiangsu Nhwa Pharmaceutical Main Business Overview
13.1.5 Jiangsu Nhwa Pharmaceutical Latest Developments
13.2 Humanwell Healthcare Group
13.2.1 Humanwell Healthcare Group Company Information
13.2.2 Humanwell Healthcare Group Medical Morphine Product Portfolios and Specifications
13.2.3 Humanwell Healthcare Group Medical Morphine Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Humanwell Healthcare Group Main Business Overview
13.2.5 Humanwell Healthcare Group Latest Developments
13.3 Mallinckrodt Pharmaceuticals
13.3.1 Mallinckrodt Pharmaceuticals Company Information
13.3.2 Mallinckrodt Pharmaceuticals Medical Morphine Product Portfolios and Specifications
13.3.3 Mallinckrodt Pharmaceuticals Medical Morphine Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Mallinckrodt Pharmaceuticals Main Business Overview
13.3.5 Mallinckrodt Pharmaceuticals Latest Developments
13.4 Hikma Pharmaceuticals
13.4.1 Hikma Pharmaceuticals Company Information
13.4.2 Hikma Pharmaceuticals Medical Morphine Product Portfolios and Specifications
13.4.3 Hikma Pharmaceuticals Medical Morphine Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Hikma Pharmaceuticals Main Business Overview
13.4.5 Hikma Pharmaceuticals Latest Developments
13.5 Viatris
13.5.1 Viatris Company Information
13.5.2 Viatris Medical Morphine Product Portfolios and Specifications
13.5.3 Viatris Medical Morphine Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Viatris Main Business Overview
13.5.5 Viatris Latest Developments
13.6 Pfizer
13.6.1 Pfizer Company Information
13.6.2 Pfizer Medical Morphine Product Portfolios and Specifications
13.6.3 Pfizer Medical Morphine Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Pfizer Main Business Overview
13.6.5 Pfizer Latest Developments
13.7 Fresenius Kabi
13.7.1 Fresenius Kabi Company Information
13.7.2 Fresenius Kabi Medical Morphine Product Portfolios and Specifications
13.7.3 Fresenius Kabi Medical Morphine Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Fresenius Kabi Main Business Overview
13.7.5 Fresenius Kabi Latest Developments
13.8 Hameln Pharma
13.8.1 Hameln Pharma Company Information
13.8.2 Hameln Pharma Medical Morphine Product Portfolios and Specifications
13.8.3 Hameln Pharma Medical Morphine Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Hameln Pharma Main Business Overview
13.8.5 Hameln Pharma Latest Developments
13.9 Teva Pharmaceutical
13.9.1 Teva Pharmaceutical Company Information
13.9.2 Teva Pharmaceutical Medical Morphine Product Portfolios and Specifications
13.9.3 Teva Pharmaceutical Medical Morphine Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Teva Pharmaceutical Main Business Overview
13.9.5 Teva Pharmaceutical Latest Developments
13.10 Sun Pharmaceutical
13.10.1 Sun Pharmaceutical Company Information
13.10.2 Sun Pharmaceutical Medical Morphine Product Portfolios and Specifications
13.10.3 Sun Pharmaceutical Medical Morphine Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Sun Pharmaceutical Main Business Overview
13.10.5 Sun Pharmaceutical Latest Developments
13.11 Amneal Pharmaceuticals
13.11.1 Amneal Pharmaceuticals Company Information
13.11.2 Amneal Pharmaceuticals Medical Morphine Product Portfolios and Specifications
13.11.3 Amneal Pharmaceuticals Medical Morphine Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 Amneal Pharmaceuticals Main Business Overview
13.11.5 Amneal Pharmaceuticals Latest Developments
13.12 Rhodes Pharmaceuticals
13.12.1 Rhodes Pharmaceuticals Company Information
13.12.2 Rhodes Pharmaceuticals Medical Morphine Product Portfolios and Specifications
13.12.3 Rhodes Pharmaceuticals Medical Morphine Sales, Revenue, Price and Gross Margin (2021-2026)
13.12.4 Rhodes Pharmaceuticals Main Business Overview
13.12.5 Rhodes Pharmaceuticals Latest Developments
13.13 Purdue Pharma
13.13.1 Purdue Pharma Company Information
13.13.2 Purdue Pharma Medical Morphine Product Portfolios and Specifications
13.13.3 Purdue Pharma Medical Morphine Sales, Revenue, Price and Gross Margin (2021-2026)
13.13.4 Purdue Pharma Main Business Overview
13.13.5 Purdue Pharma Latest Developments
13.14 Sandoz
13.14.1 Sandoz Company Information
13.14.2 Sandoz Medical Morphine Product Portfolios and Specifications
13.14.3 Sandoz Medical Morphine Sales, Revenue, Price and Gross Margin (2021-2026)
13.14.4 Sandoz Main Business Overview
13.14.5 Sandoz Latest Developments
13.15 Alcaliber
13.15.1 Alcaliber Company Information
13.15.2 Alcaliber Medical Morphine Product Portfolios and Specifications
13.15.3 Alcaliber Medical Morphine Sales, Revenue, Price and Gross Margin (2021-2026)
13.15.4 Alcaliber Main Business Overview
13.15.5 Alcaliber Latest Developments
13.16 Tasmanian Alkaloids
13.16.1 Tasmanian Alkaloids Company Information
13.16.2 Tasmanian Alkaloids Medical Morphine Product Portfolios and Specifications
13.16.3 Tasmanian Alkaloids Medical Morphine Sales, Revenue, Price and Gross Margin (2021-2026)
13.16.4 Tasmanian Alkaloids Main Business Overview
13.16.5 Tasmanian Alkaloids Latest Developments
13.17 G.L. Pharma
13.17.1 G.L. Pharma Company Information
13.17.2 G.L. Pharma Medical Morphine Product Portfolios and Specifications
13.17.3 G.L. Pharma Medical Morphine Sales, Revenue, Price and Gross Margin (2021-2026)
13.17.4 G.L. Pharma Main Business Overview
13.17.5 G.L. Pharma Latest Developments
13.18 Martindale Pharma
13.18.1 Martindale Pharma Company Information
13.18.2 Martindale Pharma Medical Morphine Product Portfolios and Specifications
13.18.3 Martindale Pharma Medical Morphine Sales, Revenue, Price and Gross Margin (2021-2026)
13.18.4 Martindale Pharma Main Business Overview
13.18.5 Martindale Pharma Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Medical Morphine Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Medical Morphine Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Immediate-Release (IR)
Table 4. Major Players of Controlled-Release (CR)
Table 5. Major Players of Sustained-Release (SR)
Table 6. Global Medical Morphine Sales by Type (2021-2026) & (K Units)
Table 7. Global Medical Morphine Sales Market Share by Type (2021-2026)
Table 8. Global Medical Morphine Revenue by Type (2021-2026) & ($ million)
Table 9. Global Medical Morphine Revenue Market Share by Type (2021-2026)
Table 10. Global Medical Morphine Sale Price by Type (2021-2026) & (US$/Unit)
Table 11. Major Players of <15 mg
Table 12. Major Players of 15–30 mg
Table 13. Major Players of 30–60 mg
Table 14. Major Players of 60–100 mg
Table 15. Major Players of >100 mg
Table 16. Global Medical Morphine Sales by Strength (2021-2026) & (K Units)
Table 17. Global Medical Morphine Sales Market Share by Strength (2021-2026)
Table 18. Global Medical Morphine Revenue by Strength (2021-2026) & ($ million)
Table 19. Global Medical Morphine Revenue Market Share by Strength (2021-2026)
Table 20. Global Medical Morphine Sale Price by Strength (2021-2026) & (US$/Unit)
Table 21. Major Players of Sterile Injectable Grade
Table 22. Major Players of Non-Sterile Oral Grade
Table 23. Global Medical Morphine Sales by Sterility (2021-2026) & (K Units)
Table 24. Global Medical Morphine Sales Market Share by Sterility (2021-2026)
Table 25. Global Medical Morphine Revenue by Sterility (2021-2026) & ($ million)
Table 26. Global Medical Morphine Revenue Market Share by Sterility (2021-2026)
Table 27. Global Medical Morphine Sale Price by Sterility (2021-2026) & (US$/Unit)
Table 28. Global Medical Morphine Sale by Application (2021-2026) & (K Units)
Table 29. Global Medical Morphine Sale Market Share by Application (2021-2026)
Table 30. Global Medical Morphine Revenue by Application (2021-2026) & ($ million)
Table 31. Global Medical Morphine Revenue Market Share by Application (2021-2026)
Table 32. Global Medical Morphine Sale Price by Application (2021-2026) & (US$/Unit)
Table 33. Global Medical Morphine Sales by Company (2021-2026) & (K Units)
Table 34. Global Medical Morphine Sales Market Share by Company (2021-2026)
Table 35. Global Medical Morphine Revenue by Company (2021-2026) & ($ millions)
Table 36. Global Medical Morphine Revenue Market Share by Company (2021-2026)
Table 37. Global Medical Morphine Sale Price by Company (2021-2026) & (US$/Unit)
Table 38. Key Manufacturers Medical Morphine Producing Area Distribution and Sales Area
Table 39. Players Medical Morphine Products Offered
Table 40. Medical Morphine Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 41. New Products and Potential Entrants
Table 42. Market M&A Activity & Strategy
Table 43. Global Medical Morphine Sales by Geographic Region (2021-2026) & (K Units)
Table 44. Global Medical Morphine Sales Market Share Geographic Region (2021-2026)
Table 45. Global Medical Morphine Revenue by Geographic Region (2021-2026) & ($ millions)
Table 46. Global Medical Morphine Revenue Market Share by Geographic Region (2021-2026)
Table 47. Global Medical Morphine Sales by Country/Region (2021-2026) & (K Units)
Table 48. Global Medical Morphine Sales Market Share by Country/Region (2021-2026)
Table 49. Global Medical Morphine Revenue by Country/Region (2021-2026) & ($ millions)
Table 50. Global Medical Morphine Revenue Market Share by Country/Region (2021-2026)
Table 51. Americas Medical Morphine Sales by Country (2021-2026) & (K Units)
Table 52. Americas Medical Morphine Sales Market Share by Country (2021-2026)
Table 53. Americas Medical Morphine Revenue by Country (2021-2026) & ($ millions)
Table 54. Americas Medical Morphine Sales by Type (2021-2026) & (K Units)
Table 55. Americas Medical Morphine Sales by Application (2021-2026) & (K Units)
Table 56. APAC Medical Morphine Sales by Region (2021-2026) & (K Units)
Table 57. APAC Medical Morphine Sales Market Share by Region (2021-2026)
Table 58. APAC Medical Morphine Revenue by Region (2021-2026) & ($ millions)
Table 59. APAC Medical Morphine Sales by Type (2021-2026) & (K Units)
Table 60. APAC Medical Morphine Sales by Application (2021-2026) & (K Units)
Table 61. Europe Medical Morphine Sales by Country (2021-2026) & (K Units)
Table 62. Europe Medical Morphine Revenue by Country (2021-2026) & ($ millions)
Table 63. Europe Medical Morphine Sales by Type (2021-2026) & (K Units)
Table 64. Europe Medical Morphine Sales by Application (2021-2026) & (K Units)
Table 65. Middle East & Africa Medical Morphine Sales by Country (2021-2026) & (K Units)
Table 66. Middle East & Africa Medical Morphine Revenue Market Share by Country (2021-2026)
Table 67. Middle East & Africa Medical Morphine Sales by Type (2021-2026) & (K Units)
Table 68. Middle East & Africa Medical Morphine Sales by Application (2021-2026) & (K Units)
Table 69. Key Market Drivers & Growth Opportunities of Medical Morphine
Table 70. Key Market Challenges & Risks of Medical Morphine
Table 71. Key Industry Trends of Medical Morphine
Table 72. Medical Morphine Raw Material
Table 73. Key Suppliers of Raw Materials
Table 74. Medical Morphine Distributors List
Table 75. Medical Morphine Customer List
Table 76. Global Medical Morphine Sales Forecast by Region (2027-2032) & (K Units)
Table 77. Global Medical Morphine Revenue Forecast by Region (2027-2032) & ($ millions)
Table 78. Americas Medical Morphine Sales Forecast by Country (2027-2032) & (K Units)
Table 79. Americas Medical Morphine Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 80. APAC Medical Morphine Sales Forecast by Region (2027-2032) & (K Units)
Table 81. APAC Medical Morphine Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 82. Europe Medical Morphine Sales Forecast by Country (2027-2032) & (K Units)
Table 83. Europe Medical Morphine Revenue Forecast by Country (2027-2032) & ($ millions)
Table 84. Middle East & Africa Medical Morphine Sales Forecast by Country (2027-2032) & (K Units)
Table 85. Middle East & Africa Medical Morphine Revenue Forecast by Country (2027-2032) & ($ millions)
Table 86. Global Medical Morphine Sales Forecast by Type (2027-2032) & (K Units)
Table 87. Global Medical Morphine Revenue Forecast by Type (2027-2032) & ($ millions)
Table 88. Global Medical Morphine Sales Forecast by Application (2027-2032) & (K Units)
Table 89. Global Medical Morphine Revenue Forecast by Application (2027-2032) & ($ millions)
Table 90. Jiangsu Nhwa Pharmaceutical Basic Information, Medical Morphine Manufacturing Base, Sales Area and Its Competitors
Table 91. Jiangsu Nhwa Pharmaceutical Medical Morphine Product Portfolios and Specifications
Table 92. Jiangsu Nhwa Pharmaceutical Medical Morphine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 93. Jiangsu Nhwa Pharmaceutical Main Business
Table 94. Jiangsu Nhwa Pharmaceutical Latest Developments
Table 95. Humanwell Healthcare Group Basic Information, Medical Morphine Manufacturing Base, Sales Area and Its Competitors
Table 96. Humanwell Healthcare Group Medical Morphine Product Portfolios and Specifications
Table 97. Humanwell Healthcare Group Medical Morphine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 98. Humanwell Healthcare Group Main Business
Table 99. Humanwell Healthcare Group Latest Developments
Table 100. Mallinckrodt Pharmaceuticals Basic Information, Medical Morphine Manufacturing Base, Sales Area and Its Competitors
Table 101. Mallinckrodt Pharmaceuticals Medical Morphine Product Portfolios and Specifications
Table 102. Mallinckrodt Pharmaceuticals Medical Morphine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 103. Mallinckrodt Pharmaceuticals Main Business
Table 104. Mallinckrodt Pharmaceuticals Latest Developments
Table 105. Hikma Pharmaceuticals Basic Information, Medical Morphine Manufacturing Base, Sales Area and Its Competitors
Table 106. Hikma Pharmaceuticals Medical Morphine Product Portfolios and Specifications
Table 107. Hikma Pharmaceuticals Medical Morphine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 108. Hikma Pharmaceuticals Main Business
Table 109. Hikma Pharmaceuticals Latest Developments
Table 110. Viatris Basic Information, Medical Morphine Manufacturing Base, Sales Area and Its Competitors
Table 111. Viatris Medical Morphine Product Portfolios and Specifications
Table 112. Viatris Medical Morphine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 113. Viatris Main Business
Table 114. Viatris Latest Developments
Table 115. Pfizer Basic Information, Medical Morphine Manufacturing Base, Sales Area and Its Competitors
Table 116. Pfizer Medical Morphine Product Portfolios and Specifications
Table 117. Pfizer Medical Morphine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 118. Pfizer Main Business
Table 119. Pfizer Latest Developments
Table 120. Fresenius Kabi Basic Information, Medical Morphine Manufacturing Base, Sales Area and Its Competitors
Table 121. Fresenius Kabi Medical Morphine Product Portfolios and Specifications
Table 122. Fresenius Kabi Medical Morphine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 123. Fresenius Kabi Main Business
Table 124. Fresenius Kabi Latest Developments
Table 125. Hameln Pharma Basic Information, Medical Morphine Manufacturing Base, Sales Area and Its Competitors
Table 126. Hameln Pharma Medical Morphine Product Portfolios and Specifications
Table 127. Hameln Pharma Medical Morphine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 128. Hameln Pharma Main Business
Table 129. Hameln Pharma Latest Developments
Table 130. Teva Pharmaceutical Basic Information, Medical Morphine Manufacturing Base, Sales Area and Its Competitors
Table 131. Teva Pharmaceutical Medical Morphine Product Portfolios and Specifications
Table 132. Teva Pharmaceutical Medical Morphine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 133. Teva Pharmaceutical Main Business
Table 134. Teva Pharmaceutical Latest Developments
Table 135. Sun Pharmaceutical Basic Information, Medical Morphine Manufacturing Base, Sales Area and Its Competitors
Table 136. Sun Pharmaceutical Medical Morphine Product Portfolios and Specifications
Table 137. Sun Pharmaceutical Medical Morphine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 138. Sun Pharmaceutical Main Business
Table 139. Sun Pharmaceutical Latest Developments
Table 140. Amneal Pharmaceuticals Basic Information, Medical Morphine Manufacturing Base, Sales Area and Its Competitors
Table 141. Amneal Pharmaceuticals Medical Morphine Product Portfolios and Specifications
Table 142. Amneal Pharmaceuticals Medical Morphine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 143. Amneal Pharmaceuticals Main Business
Table 144. Amneal Pharmaceuticals Latest Developments
Table 145. Rhodes Pharmaceuticals Basic Information, Medical Morphine Manufacturing Base, Sales Area and Its Competitors
Table 146. Rhodes Pharmaceuticals Medical Morphine Product Portfolios and Specifications
Table 147. Rhodes Pharmaceuticals Medical Morphine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 148. Rhodes Pharmaceuticals Main Business
Table 149. Rhodes Pharmaceuticals Latest Developments
Table 150. Purdue Pharma Basic Information, Medical Morphine Manufacturing Base, Sales Area and Its Competitors
Table 151. Purdue Pharma Medical Morphine Product Portfolios and Specifications
Table 152. Purdue Pharma Medical Morphine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 153. Purdue Pharma Main Business
Table 154. Purdue Pharma Latest Developments
Table 155. Sandoz Basic Information, Medical Morphine Manufacturing Base, Sales Area and Its Competitors
Table 156. Sandoz Medical Morphine Product Portfolios and Specifications
Table 157. Sandoz Medical Morphine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 158. Sandoz Main Business
Table 159. Sandoz Latest Developments
Table 160. Alcaliber Basic Information, Medical Morphine Manufacturing Base, Sales Area and Its Competitors
Table 161. Alcaliber Medical Morphine Product Portfolios and Specifications
Table 162. Alcaliber Medical Morphine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 163. Alcaliber Main Business
Table 164. Alcaliber Latest Developments
Table 165. Tasmanian Alkaloids Basic Information, Medical Morphine Manufacturing Base, Sales Area and Its Competitors
Table 166. Tasmanian Alkaloids Medical Morphine Product Portfolios and Specifications
Table 167. Tasmanian Alkaloids Medical Morphine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 168. Tasmanian Alkaloids Main Business
Table 169. Tasmanian Alkaloids Latest Developments
Table 170. G.L. Pharma Basic Information, Medical Morphine Manufacturing Base, Sales Area and Its Competitors
Table 171. G.L. Pharma Medical Morphine Product Portfolios and Specifications
Table 172. G.L. Pharma Medical Morphine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 173. G.L. Pharma Main Business
Table 174. G.L. Pharma Latest Developments
Table 175. Martindale Pharma Basic Information, Medical Morphine Manufacturing Base, Sales Area and Its Competitors
Table 176. Martindale Pharma Medical Morphine Product Portfolios and Specifications
Table 177. Martindale Pharma Medical Morphine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 178. Martindale Pharma Main Business
Table 179. Martindale Pharma Latest Developments
Table 1. Medical Morphine Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Medical Morphine Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Immediate-Release (IR)
Table 4. Major Players of Controlled-Release (CR)
Table 5. Major Players of Sustained-Release (SR)
Table 6. Global Medical Morphine Sales by Type (2021-2026) & (K Units)
Table 7. Global Medical Morphine Sales Market Share by Type (2021-2026)
Table 8. Global Medical Morphine Revenue by Type (2021-2026) & ($ million)
Table 9. Global Medical Morphine Revenue Market Share by Type (2021-2026)
Table 10. Global Medical Morphine Sale Price by Type (2021-2026) & (US$/Unit)
Table 11. Major Players of <15 mg
Table 12. Major Players of 15–30 mg
Table 13. Major Players of 30–60 mg
Table 14. Major Players of 60–100 mg
Table 15. Major Players of >100 mg
Table 16. Global Medical Morphine Sales by Strength (2021-2026) & (K Units)
Table 17. Global Medical Morphine Sales Market Share by Strength (2021-2026)
Table 18. Global Medical Morphine Revenue by Strength (2021-2026) & ($ million)
Table 19. Global Medical Morphine Revenue Market Share by Strength (2021-2026)
Table 20. Global Medical Morphine Sale Price by Strength (2021-2026) & (US$/Unit)
Table 21. Major Players of Sterile Injectable Grade
Table 22. Major Players of Non-Sterile Oral Grade
Table 23. Global Medical Morphine Sales by Sterility (2021-2026) & (K Units)
Table 24. Global Medical Morphine Sales Market Share by Sterility (2021-2026)
Table 25. Global Medical Morphine Revenue by Sterility (2021-2026) & ($ million)
Table 26. Global Medical Morphine Revenue Market Share by Sterility (2021-2026)
Table 27. Global Medical Morphine Sale Price by Sterility (2021-2026) & (US$/Unit)
Table 28. Global Medical Morphine Sale by Application (2021-2026) & (K Units)
Table 29. Global Medical Morphine Sale Market Share by Application (2021-2026)
Table 30. Global Medical Morphine Revenue by Application (2021-2026) & ($ million)
Table 31. Global Medical Morphine Revenue Market Share by Application (2021-2026)
Table 32. Global Medical Morphine Sale Price by Application (2021-2026) & (US$/Unit)
Table 33. Global Medical Morphine Sales by Company (2021-2026) & (K Units)
Table 34. Global Medical Morphine Sales Market Share by Company (2021-2026)
Table 35. Global Medical Morphine Revenue by Company (2021-2026) & ($ millions)
Table 36. Global Medical Morphine Revenue Market Share by Company (2021-2026)
Table 37. Global Medical Morphine Sale Price by Company (2021-2026) & (US$/Unit)
Table 38. Key Manufacturers Medical Morphine Producing Area Distribution and Sales Area
Table 39. Players Medical Morphine Products Offered
Table 40. Medical Morphine Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 41. New Products and Potential Entrants
Table 42. Market M&A Activity & Strategy
Table 43. Global Medical Morphine Sales by Geographic Region (2021-2026) & (K Units)
Table 44. Global Medical Morphine Sales Market Share Geographic Region (2021-2026)
Table 45. Global Medical Morphine Revenue by Geographic Region (2021-2026) & ($ millions)
Table 46. Global Medical Morphine Revenue Market Share by Geographic Region (2021-2026)
Table 47. Global Medical Morphine Sales by Country/Region (2021-2026) & (K Units)
Table 48. Global Medical Morphine Sales Market Share by Country/Region (2021-2026)
Table 49. Global Medical Morphine Revenue by Country/Region (2021-2026) & ($ millions)
Table 50. Global Medical Morphine Revenue Market Share by Country/Region (2021-2026)
Table 51. Americas Medical Morphine Sales by Country (2021-2026) & (K Units)
Table 52. Americas Medical Morphine Sales Market Share by Country (2021-2026)
Table 53. Americas Medical Morphine Revenue by Country (2021-2026) & ($ millions)
Table 54. Americas Medical Morphine Sales by Type (2021-2026) & (K Units)
Table 55. Americas Medical Morphine Sales by Application (2021-2026) & (K Units)
Table 56. APAC Medical Morphine Sales by Region (2021-2026) & (K Units)
Table 57. APAC Medical Morphine Sales Market Share by Region (2021-2026)
Table 58. APAC Medical Morphine Revenue by Region (2021-2026) & ($ millions)
Table 59. APAC Medical Morphine Sales by Type (2021-2026) & (K Units)
Table 60. APAC Medical Morphine Sales by Application (2021-2026) & (K Units)
Table 61. Europe Medical Morphine Sales by Country (2021-2026) & (K Units)
Table 62. Europe Medical Morphine Revenue by Country (2021-2026) & ($ millions)
Table 63. Europe Medical Morphine Sales by Type (2021-2026) & (K Units)
Table 64. Europe Medical Morphine Sales by Application (2021-2026) & (K Units)
Table 65. Middle East & Africa Medical Morphine Sales by Country (2021-2026) & (K Units)
Table 66. Middle East & Africa Medical Morphine Revenue Market Share by Country (2021-2026)
Table 67. Middle East & Africa Medical Morphine Sales by Type (2021-2026) & (K Units)
Table 68. Middle East & Africa Medical Morphine Sales by Application (2021-2026) & (K Units)
Table 69. Key Market Drivers & Growth Opportunities of Medical Morphine
Table 70. Key Market Challenges & Risks of Medical Morphine
Table 71. Key Industry Trends of Medical Morphine
Table 72. Medical Morphine Raw Material
Table 73. Key Suppliers of Raw Materials
Table 74. Medical Morphine Distributors List
Table 75. Medical Morphine Customer List
Table 76. Global Medical Morphine Sales Forecast by Region (2027-2032) & (K Units)
Table 77. Global Medical Morphine Revenue Forecast by Region (2027-2032) & ($ millions)
Table 78. Americas Medical Morphine Sales Forecast by Country (2027-2032) & (K Units)
Table 79. Americas Medical Morphine Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 80. APAC Medical Morphine Sales Forecast by Region (2027-2032) & (K Units)
Table 81. APAC Medical Morphine Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 82. Europe Medical Morphine Sales Forecast by Country (2027-2032) & (K Units)
Table 83. Europe Medical Morphine Revenue Forecast by Country (2027-2032) & ($ millions)
Table 84. Middle East & Africa Medical Morphine Sales Forecast by Country (2027-2032) & (K Units)
Table 85. Middle East & Africa Medical Morphine Revenue Forecast by Country (2027-2032) & ($ millions)
Table 86. Global Medical Morphine Sales Forecast by Type (2027-2032) & (K Units)
Table 87. Global Medical Morphine Revenue Forecast by Type (2027-2032) & ($ millions)
Table 88. Global Medical Morphine Sales Forecast by Application (2027-2032) & (K Units)
Table 89. Global Medical Morphine Revenue Forecast by Application (2027-2032) & ($ millions)
Table 90. Jiangsu Nhwa Pharmaceutical Basic Information, Medical Morphine Manufacturing Base, Sales Area and Its Competitors
Table 91. Jiangsu Nhwa Pharmaceutical Medical Morphine Product Portfolios and Specifications
Table 92. Jiangsu Nhwa Pharmaceutical Medical Morphine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 93. Jiangsu Nhwa Pharmaceutical Main Business
Table 94. Jiangsu Nhwa Pharmaceutical Latest Developments
Table 95. Humanwell Healthcare Group Basic Information, Medical Morphine Manufacturing Base, Sales Area and Its Competitors
Table 96. Humanwell Healthcare Group Medical Morphine Product Portfolios and Specifications
Table 97. Humanwell Healthcare Group Medical Morphine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 98. Humanwell Healthcare Group Main Business
Table 99. Humanwell Healthcare Group Latest Developments
Table 100. Mallinckrodt Pharmaceuticals Basic Information, Medical Morphine Manufacturing Base, Sales Area and Its Competitors
Table 101. Mallinckrodt Pharmaceuticals Medical Morphine Product Portfolios and Specifications
Table 102. Mallinckrodt Pharmaceuticals Medical Morphine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 103. Mallinckrodt Pharmaceuticals Main Business
Table 104. Mallinckrodt Pharmaceuticals Latest Developments
Table 105. Hikma Pharmaceuticals Basic Information, Medical Morphine Manufacturing Base, Sales Area and Its Competitors
Table 106. Hikma Pharmaceuticals Medical Morphine Product Portfolios and Specifications
Table 107. Hikma Pharmaceuticals Medical Morphine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 108. Hikma Pharmaceuticals Main Business
Table 109. Hikma Pharmaceuticals Latest Developments
Table 110. Viatris Basic Information, Medical Morphine Manufacturing Base, Sales Area and Its Competitors
Table 111. Viatris Medical Morphine Product Portfolios and Specifications
Table 112. Viatris Medical Morphine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 113. Viatris Main Business
Table 114. Viatris Latest Developments
Table 115. Pfizer Basic Information, Medical Morphine Manufacturing Base, Sales Area and Its Competitors
Table 116. Pfizer Medical Morphine Product Portfolios and Specifications
Table 117. Pfizer Medical Morphine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 118. Pfizer Main Business
Table 119. Pfizer Latest Developments
Table 120. Fresenius Kabi Basic Information, Medical Morphine Manufacturing Base, Sales Area and Its Competitors
Table 121. Fresenius Kabi Medical Morphine Product Portfolios and Specifications
Table 122. Fresenius Kabi Medical Morphine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 123. Fresenius Kabi Main Business
Table 124. Fresenius Kabi Latest Developments
Table 125. Hameln Pharma Basic Information, Medical Morphine Manufacturing Base, Sales Area and Its Competitors
Table 126. Hameln Pharma Medical Morphine Product Portfolios and Specifications
Table 127. Hameln Pharma Medical Morphine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 128. Hameln Pharma Main Business
Table 129. Hameln Pharma Latest Developments
Table 130. Teva Pharmaceutical Basic Information, Medical Morphine Manufacturing Base, Sales Area and Its Competitors
Table 131. Teva Pharmaceutical Medical Morphine Product Portfolios and Specifications
Table 132. Teva Pharmaceutical Medical Morphine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 133. Teva Pharmaceutical Main Business
Table 134. Teva Pharmaceutical Latest Developments
Table 135. Sun Pharmaceutical Basic Information, Medical Morphine Manufacturing Base, Sales Area and Its Competitors
Table 136. Sun Pharmaceutical Medical Morphine Product Portfolios and Specifications
Table 137. Sun Pharmaceutical Medical Morphine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 138. Sun Pharmaceutical Main Business
Table 139. Sun Pharmaceutical Latest Developments
Table 140. Amneal Pharmaceuticals Basic Information, Medical Morphine Manufacturing Base, Sales Area and Its Competitors
Table 141. Amneal Pharmaceuticals Medical Morphine Product Portfolios and Specifications
Table 142. Amneal Pharmaceuticals Medical Morphine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 143. Amneal Pharmaceuticals Main Business
Table 144. Amneal Pharmaceuticals Latest Developments
Table 145. Rhodes Pharmaceuticals Basic Information, Medical Morphine Manufacturing Base, Sales Area and Its Competitors
Table 146. Rhodes Pharmaceuticals Medical Morphine Product Portfolios and Specifications
Table 147. Rhodes Pharmaceuticals Medical Morphine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 148. Rhodes Pharmaceuticals Main Business
Table 149. Rhodes Pharmaceuticals Latest Developments
Table 150. Purdue Pharma Basic Information, Medical Morphine Manufacturing Base, Sales Area and Its Competitors
Table 151. Purdue Pharma Medical Morphine Product Portfolios and Specifications
Table 152. Purdue Pharma Medical Morphine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 153. Purdue Pharma Main Business
Table 154. Purdue Pharma Latest Developments
Table 155. Sandoz Basic Information, Medical Morphine Manufacturing Base, Sales Area and Its Competitors
Table 156. Sandoz Medical Morphine Product Portfolios and Specifications
Table 157. Sandoz Medical Morphine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 158. Sandoz Main Business
Table 159. Sandoz Latest Developments
Table 160. Alcaliber Basic Information, Medical Morphine Manufacturing Base, Sales Area and Its Competitors
Table 161. Alcaliber Medical Morphine Product Portfolios and Specifications
Table 162. Alcaliber Medical Morphine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 163. Alcaliber Main Business
Table 164. Alcaliber Latest Developments
Table 165. Tasmanian Alkaloids Basic Information, Medical Morphine Manufacturing Base, Sales Area and Its Competitors
Table 166. Tasmanian Alkaloids Medical Morphine Product Portfolios and Specifications
Table 167. Tasmanian Alkaloids Medical Morphine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 168. Tasmanian Alkaloids Main Business
Table 169. Tasmanian Alkaloids Latest Developments
Table 170. G.L. Pharma Basic Information, Medical Morphine Manufacturing Base, Sales Area and Its Competitors
Table 171. G.L. Pharma Medical Morphine Product Portfolios and Specifications
Table 172. G.L. Pharma Medical Morphine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 173. G.L. Pharma Main Business
Table 174. G.L. Pharma Latest Developments
Table 175. Martindale Pharma Basic Information, Medical Morphine Manufacturing Base, Sales Area and Its Competitors
Table 176. Martindale Pharma Medical Morphine Product Portfolios and Specifications
Table 177. Martindale Pharma Medical Morphine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 178. Martindale Pharma Main Business
Table 179. Martindale Pharma Latest Developments
LIST OF FIGURES
Figure 1. Picture of Medical Morphine
Figure 2. Medical Morphine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Medical Morphine Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Medical Morphine Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Medical Morphine Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Medical Morphine Sales Market Share by Country/Region (2025)
Figure 10. Medical Morphine Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Immediate-Release (IR)
Figure 12. Product Picture of Controlled-Release (CR)
Figure 13. Product Picture of Sustained-Release (SR)
Figure 14. Global Medical Morphine Sales Market Share by Type in 2026
Figure 15. Global Medical Morphine Revenue Market Share by Type (2021-2026)
Figure 16. Product Picture of <15 mg
Figure 17. Product Picture of 15–30 mg
Figure 18. Product Picture of 30–60 mg
Figure 19. Product Picture of 60–100 mg
Figure 20. Product Picture of >100 mg
Figure 21. Global Medical Morphine Sales Market Share by Strength in 2026
Figure 22. Global Medical Morphine Revenue Market Share by Strength (2021-2026)
Figure 23. Product Picture of Sterile Injectable Grade
Figure 24. Product Picture of Non-Sterile Oral Grade
Figure 25. Global Medical Morphine Sales Market Share by Sterility in 2026
Figure 26. Global Medical Morphine Revenue Market Share by Sterility (2021-2026)
Figure 27. Medical Morphine Consumed in Acute Pain Management
Figure 28. Global Medical Morphine Market: Acute Pain Management (2021-2026) & (K Units)
Figure 29. Medical Morphine Consumed in Chronic Pain Management
Figure 30. Global Medical Morphine Market: Chronic Pain Management (2021-2026) & (K Units)
Figure 31. Global Medical Morphine Sale Market Share by Application (2025)
Figure 32. Global Medical Morphine Revenue Market Share by Application in 2025
Figure 33. Medical Morphine Sales by Company in 2025 (K Units)
Figure 34. Global Medical Morphine Sales Market Share by Company in 2025
Figure 35. Medical Morphine Revenue by Company in 2025 ($ millions)
Figure 36. Global Medical Morphine Revenue Market Share by Company in 2025
Figure 37. Global Medical Morphine Sales Market Share by Geographic Region (2021-2026)
Figure 38. Global Medical Morphine Revenue Market Share by Geographic Region in 2025
Figure 39. Americas Medical Morphine Sales 2021-2026 (K Units)
Figure 40. Americas Medical Morphine Revenue 2021-2026 ($ millions)
Figure 41. APAC Medical Morphine Sales 2021-2026 (K Units)
Figure 42. APAC Medical Morphine Revenue 2021-2026 ($ millions)
Figure 43. Europe Medical Morphine Sales 2021-2026 (K Units)
Figure 44. Europe Medical Morphine Revenue 2021-2026 ($ millions)
Figure 45. Middle East & Africa Medical Morphine Sales 2021-2026 (K Units)
Figure 46. Middle East & Africa Medical Morphine Revenue 2021-2026 ($ millions)
Figure 47. Americas Medical Morphine Sales Market Share by Country in 2025
Figure 48. Americas Medical Morphine Revenue Market Share by Country (2021-2026)
Figure 49. Americas Medical Morphine Sales Market Share by Type (2021-2026)
Figure 50. Americas Medical Morphine Sales Market Share by Application (2021-2026)
Figure 51. United States Medical Morphine Revenue Growth 2021-2026 ($ millions)
Figure 52. Canada Medical Morphine Revenue Growth 2021-2026 ($ millions)
Figure 53. Mexico Medical Morphine Revenue Growth 2021-2026 ($ millions)
Figure 54. Brazil Medical Morphine Revenue Growth 2021-2026 ($ millions)
Figure 55. APAC Medical Morphine Sales Market Share by Region in 2025
Figure 56. APAC Medical Morphine Revenue Market Share by Region (2021-2026)
Figure 57. APAC Medical Morphine Sales Market Share by Type (2021-2026)
Figure 58. APAC Medical Morphine Sales Market Share by Application (2021-2026)
Figure 59. China Medical Morphine Revenue Growth 2021-2026 ($ millions)
Figure 60. Japan Medical Morphine Revenue Growth 2021-2026 ($ millions)
Figure 61. South Korea Medical Morphine Revenue Growth 2021-2026 ($ millions)
Figure 62. Southeast Asia Medical Morphine Revenue Growth 2021-2026 ($ millions)
Figure 63. India Medical Morphine Revenue Growth 2021-2026 ($ millions)
Figure 64. Australia Medical Morphine Revenue Growth 2021-2026 ($ millions)
Figure 65. China Taiwan Medical Morphine Revenue Growth 2021-2026 ($ millions)
Figure 66. Europe Medical Morphine Sales Market Share by Country in 2025
Figure 67. Europe Medical Morphine Revenue Market Share by Country (2021-2026)
Figure 68. Europe Medical Morphine Sales Market Share by Type (2021-2026)
Figure 69. Europe Medical Morphine Sales Market Share by Application (2021-2026)
Figure 70. Germany Medical Morphine Revenue Growth 2021-2026 ($ millions)
Figure 71. France Medical Morphine Revenue Growth 2021-2026 ($ millions)
Figure 72. UK Medical Morphine Revenue Growth 2021-2026 ($ millions)
Figure 73. Italy Medical Morphine Revenue Growth 2021-2026 ($ millions)
Figure 74. Russia Medical Morphine Revenue Growth 2021-2026 ($ millions)
Figure 75. Middle East & Africa Medical Morphine Sales Market Share by Country (2021-2026)
Figure 76. Middle East & Africa Medical Morphine Sales Market Share by Type (2021-2026)
Figure 77. Middle East & Africa Medical Morphine Sales Market Share by Application (2021-2026)
Figure 78. Egypt Medical Morphine Revenue Growth 2021-2026 ($ millions)
Figure 79. South Africa Medical Morphine Revenue Growth 2021-2026 ($ millions)
Figure 80. Israel Medical Morphine Revenue Growth 2021-2026 ($ millions)
Figure 81. Turkey Medical Morphine Revenue Growth 2021-2026 ($ millions)
Figure 82. GCC Countries Medical Morphine Revenue Growth 2021-2026 ($ millions)
Figure 83. Manufacturing Cost Structure Analysis of Medical Morphine in 2026
Figure 84. Manufacturing Process Analysis of Medical Morphine
Figure 85. Industry Chain Structure of Medical Morphine
Figure 86. Channels of Distribution
Figure 87. Global Medical Morphine Sales Market Forecast by Region (2027-2032)
Figure 88. Global Medical Morphine Revenue Market Share Forecast by Region (2027-2032)
Figure 89. Global Medical Morphine Sales Market Share Forecast by Type (2027-2032)
Figure 90. Global Medical Morphine Revenue Market Share Forecast by Type (2027-2032)
Figure 91. Global Medical Morphine Sales Market Share Forecast by Application (2027-2032)
Figure 92. Global Medical Morphine Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of Medical Morphine
Figure 2. Medical Morphine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Medical Morphine Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Medical Morphine Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Medical Morphine Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Medical Morphine Sales Market Share by Country/Region (2025)
Figure 10. Medical Morphine Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Immediate-Release (IR)
Figure 12. Product Picture of Controlled-Release (CR)
Figure 13. Product Picture of Sustained-Release (SR)
Figure 14. Global Medical Morphine Sales Market Share by Type in 2026
Figure 15. Global Medical Morphine Revenue Market Share by Type (2021-2026)
Figure 16. Product Picture of <15 mg
Figure 17. Product Picture of 15–30 mg
Figure 18. Product Picture of 30–60 mg
Figure 19. Product Picture of 60–100 mg
Figure 20. Product Picture of >100 mg
Figure 21. Global Medical Morphine Sales Market Share by Strength in 2026
Figure 22. Global Medical Morphine Revenue Market Share by Strength (2021-2026)
Figure 23. Product Picture of Sterile Injectable Grade
Figure 24. Product Picture of Non-Sterile Oral Grade
Figure 25. Global Medical Morphine Sales Market Share by Sterility in 2026
Figure 26. Global Medical Morphine Revenue Market Share by Sterility (2021-2026)
Figure 27. Medical Morphine Consumed in Acute Pain Management
Figure 28. Global Medical Morphine Market: Acute Pain Management (2021-2026) & (K Units)
Figure 29. Medical Morphine Consumed in Chronic Pain Management
Figure 30. Global Medical Morphine Market: Chronic Pain Management (2021-2026) & (K Units)
Figure 31. Global Medical Morphine Sale Market Share by Application (2025)
Figure 32. Global Medical Morphine Revenue Market Share by Application in 2025
Figure 33. Medical Morphine Sales by Company in 2025 (K Units)
Figure 34. Global Medical Morphine Sales Market Share by Company in 2025
Figure 35. Medical Morphine Revenue by Company in 2025 ($ millions)
Figure 36. Global Medical Morphine Revenue Market Share by Company in 2025
Figure 37. Global Medical Morphine Sales Market Share by Geographic Region (2021-2026)
Figure 38. Global Medical Morphine Revenue Market Share by Geographic Region in 2025
Figure 39. Americas Medical Morphine Sales 2021-2026 (K Units)
Figure 40. Americas Medical Morphine Revenue 2021-2026 ($ millions)
Figure 41. APAC Medical Morphine Sales 2021-2026 (K Units)
Figure 42. APAC Medical Morphine Revenue 2021-2026 ($ millions)
Figure 43. Europe Medical Morphine Sales 2021-2026 (K Units)
Figure 44. Europe Medical Morphine Revenue 2021-2026 ($ millions)
Figure 45. Middle East & Africa Medical Morphine Sales 2021-2026 (K Units)
Figure 46. Middle East & Africa Medical Morphine Revenue 2021-2026 ($ millions)
Figure 47. Americas Medical Morphine Sales Market Share by Country in 2025
Figure 48. Americas Medical Morphine Revenue Market Share by Country (2021-2026)
Figure 49. Americas Medical Morphine Sales Market Share by Type (2021-2026)
Figure 50. Americas Medical Morphine Sales Market Share by Application (2021-2026)
Figure 51. United States Medical Morphine Revenue Growth 2021-2026 ($ millions)
Figure 52. Canada Medical Morphine Revenue Growth 2021-2026 ($ millions)
Figure 53. Mexico Medical Morphine Revenue Growth 2021-2026 ($ millions)
Figure 54. Brazil Medical Morphine Revenue Growth 2021-2026 ($ millions)
Figure 55. APAC Medical Morphine Sales Market Share by Region in 2025
Figure 56. APAC Medical Morphine Revenue Market Share by Region (2021-2026)
Figure 57. APAC Medical Morphine Sales Market Share by Type (2021-2026)
Figure 58. APAC Medical Morphine Sales Market Share by Application (2021-2026)
Figure 59. China Medical Morphine Revenue Growth 2021-2026 ($ millions)
Figure 60. Japan Medical Morphine Revenue Growth 2021-2026 ($ millions)
Figure 61. South Korea Medical Morphine Revenue Growth 2021-2026 ($ millions)
Figure 62. Southeast Asia Medical Morphine Revenue Growth 2021-2026 ($ millions)
Figure 63. India Medical Morphine Revenue Growth 2021-2026 ($ millions)
Figure 64. Australia Medical Morphine Revenue Growth 2021-2026 ($ millions)
Figure 65. China Taiwan Medical Morphine Revenue Growth 2021-2026 ($ millions)
Figure 66. Europe Medical Morphine Sales Market Share by Country in 2025
Figure 67. Europe Medical Morphine Revenue Market Share by Country (2021-2026)
Figure 68. Europe Medical Morphine Sales Market Share by Type (2021-2026)
Figure 69. Europe Medical Morphine Sales Market Share by Application (2021-2026)
Figure 70. Germany Medical Morphine Revenue Growth 2021-2026 ($ millions)
Figure 71. France Medical Morphine Revenue Growth 2021-2026 ($ millions)
Figure 72. UK Medical Morphine Revenue Growth 2021-2026 ($ millions)
Figure 73. Italy Medical Morphine Revenue Growth 2021-2026 ($ millions)
Figure 74. Russia Medical Morphine Revenue Growth 2021-2026 ($ millions)
Figure 75. Middle East & Africa Medical Morphine Sales Market Share by Country (2021-2026)
Figure 76. Middle East & Africa Medical Morphine Sales Market Share by Type (2021-2026)
Figure 77. Middle East & Africa Medical Morphine Sales Market Share by Application (2021-2026)
Figure 78. Egypt Medical Morphine Revenue Growth 2021-2026 ($ millions)
Figure 79. South Africa Medical Morphine Revenue Growth 2021-2026 ($ millions)
Figure 80. Israel Medical Morphine Revenue Growth 2021-2026 ($ millions)
Figure 81. Turkey Medical Morphine Revenue Growth 2021-2026 ($ millions)
Figure 82. GCC Countries Medical Morphine Revenue Growth 2021-2026 ($ millions)
Figure 83. Manufacturing Cost Structure Analysis of Medical Morphine in 2026
Figure 84. Manufacturing Process Analysis of Medical Morphine
Figure 85. Industry Chain Structure of Medical Morphine
Figure 86. Channels of Distribution
Figure 87. Global Medical Morphine Sales Market Forecast by Region (2027-2032)
Figure 88. Global Medical Morphine Revenue Market Share Forecast by Region (2027-2032)
Figure 89. Global Medical Morphine Sales Market Share Forecast by Type (2027-2032)
Figure 90. Global Medical Morphine Revenue Market Share Forecast by Type (2027-2032)
Figure 91. Global Medical Morphine Sales Market Share Forecast by Application (2027-2032)
Figure 92. Global Medical Morphine Revenue Market Share Forecast by Application (2027-2032)
